C3aR Plays Both Sides in Regulating Resistance to Bacterial Infections

Overview

Journal PLoS Pathog

Specialty Microbiology

Date 2022 Aug 4

PMID 35925892

Authors

Jesse A Corcoran

Brooke A Napier

Affiliations

Soon will be listed here.

Abstract

Activation of the complement pathway results in the production of bioactive C3a, a product of C3 cleavage, which interacts with membrane-bound receptor C3aR to regulate innate immune cell function and outcome of bacterial infection. Specifically, previous research has identified mechanistically distinct and cell type-specific roles for C3aR in regulating innate immune cell inflammatory state, antimicrobial killing capacity, and metabolism. Historically, the production of C3a has been relegated to the serum; however, recent studies have provided evidence that various cell types can produce intracellular C3a that stimulates intracellular C3aR. In light of these new results, it is imperative that we revisit previous studies regarding the role of C3aR in controlling bacterial infections and analyze these results in the context of both extracellular and intracellular C3a production and C3aR activation. Thus, this review will cover specific roles of C3aR in driving cell type-specific and tissue specific responses during bacterial infections and emphasize the contribution of the C3a-C3aR axis in regulating host resistance to bacterial infection.

Citing Articles

Inhibition of C3a/C3aR by SB290157 Attenuates Neuroinflammation via PKC/P38/NLRP3 Signaling Pathway After Intracerebral Hemorrhage.

Qi D, Wei P, Cui Y, Lenahan C, Tao X, Jin P Neurocrit Care. 2025; .

PMID: 40045037 DOI: 10.1007/s12028-025-02226-z.

Complement is primarily activated in the lung in a mouse model of severe COVID-19.

Szachowicz P, Wohlford-Lenane C, Donelson C, Ghimire S, Thurman A, Xue B iScience. 2025; 28(3):111930.

PMID: 40034849 PMC: 11875145. DOI: 10.1016/j.isci.2025.111930.

A predominately pulmonary activation of complement in a mouse model of severe COVID-19.

Szachowicz P, Wohlford-Lenane C, Heinen C, Ghimire S, Xue B, Boly T bioRxiv. 2024; .

PMID: 38895461 PMC: 11185570. DOI: 10.1101/2024.05.31.596892.

Human Amniotic MSC Response in LPS-Stimulated Ascites from Patients with Cirrhosis: FOXO1 Gene and Th17 Activation in Enhanced Antibacterial Activation.

Pampalone M, Cuscino N, Iannolo G, Amico G, Ricordi C, Vitale G Int J Mol Sci. 2024; 25(5).

PMID: 38474048 PMC: 10932448. DOI: 10.3390/ijms25052801.

Subcutaneous Tocilizumab May Be Effective in Refractory Fibromyalgia Patients.

Tang K, Liao T, Chen Y, Chen D, Lai K Biomedicines. 2023; 11(7).

PMID: 37509414 PMC: 10376766. DOI: 10.3390/biomedicines11071774.

References

Wu K, Zhang T, Zhao G, Ma N, Zhao S, Wang N . The C3a/C3aR axis mediates anti-inflammatory activity and protects against uropathogenic E coli-induced kidney injury in mice. Kidney Int. 2019; 96(3):612-627. DOI: 10.1016/j.kint.2019.03.005. View

Brennan F, Jogia T, Gillespie E, Blomster L, Li X, Nowlan B . Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2. JCI Insight. 2019; 4(9). PMC: 6538362. DOI: 10.1172/jci.insight.98254. View

Gupta K, Subramanian H, Klos A, Ali H . Phosphorylation of C3a receptor at multiple sites mediates desensitization, β-arrestin-2 recruitment and inhibition of NF-κB activity in mast cells. PLoS One. 2012; 7(10):e46369. PMC: 3471852. DOI: 10.1371/journal.pone.0046369. View

Liszewski M, Kolev M, Le Friec G, Leung M, Bertram P, Fara A . Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity. 2013; 39(6):1143-57. PMC: 3865363. DOI: 10.1016/j.immuni.2013.10.018. View

Virji M . Pathogenic neisseriae: surface modulation, pathogenesis and infection control. Nat Rev Microbiol. 2009; 7(4):274-86. DOI: 10.1038/nrmicro2097. View

Rusconi B, Greub G . Chlamydiales and the innate immune response: friend or foe?. FEMS Immunol Med Microbiol. 2011; 61(3):231-44. DOI: 10.1111/j.1574-695X.2010.00772.x. View

Metzemaekers M, Gouwy M, Proost P . Neutrophil chemoattractant receptors in health and disease: double-edged swords. Cell Mol Immunol. 2020; 17(5):433-450. PMC: 7192912. DOI: 10.1038/s41423-020-0412-0. View

Calame D, Mueller-Ortiz S, Morales J, Wetsel R . The C5a anaphylatoxin receptor (C5aR1) protects against Listeria monocytogenes infection by inhibiting type 1 IFN expression. J Immunol. 2014; 193(10):5099-107. PMC: 4295506. DOI: 10.4049/jimmunol.1401750. View

Olson P, Hunstad D . Subversion of Host Innate Immunity by Uropathogenic Escherichia coli. Pathogens. 2016; 5(1). PMC: 4810123. DOI: 10.3390/pathogens5010002. View

10.

Le Negrate G, Krieg A, Faustin B, Loeffler M, Godzik A, Krajewski S . ChlaDub1 of Chlamydia trachomatis suppresses NF-kappaB activation and inhibits IkappaBalpha ubiquitination and degradation. Cell Microbiol. 2008; 10(9):1879-92. DOI: 10.1111/j.1462-5822.2008.01178.x. View

11.

Elwell C, Mirrashidi K, Engel J . Chlamydia cell biology and pathogenesis. Nat Rev Microbiol. 2016; 14(6):385-400. PMC: 4886739. DOI: 10.1038/nrmicro.2016.30. View

12.

Delamarre L, Pack M, Chang H, Mellman I, Trombetta E . Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science. 2005; 307(5715):1630-4. DOI: 10.1126/science.1108003. View

13.

Manohar P, Loh B, Nachimuthu R, Hua X, Welburn S, Leptihn S . Secondary Bacterial Infections in Patients With Viral Pneumonia. Front Med (Lausanne). 2020; 7:420. PMC: 7419580. DOI: 10.3389/fmed.2020.00420. View

14.

Wu M, Brennan F, Lynch J, Mantovani S, Phipps S, Wetsel R . The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization. Proc Natl Acad Sci U S A. 2013; 110(23):9439-44. PMC: 3677481. DOI: 10.1073/pnas.1218815110. View

15.

Criss A, Seifert H . A bacterial siren song: intimate interactions between Neisseria and neutrophils. Nat Rev Microbiol. 2012; 10(3):178-90. PMC: 3569855. DOI: 10.1038/nrmicro2713. View

16.

Hauser A . The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol. 2009; 7(9):654-65. PMC: 2766515. DOI: 10.1038/nrmicro2199. View

17.

Martin U, Bock D, Arseniev L, Tornetta M, Ames R, Bautsch W . The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes. J Exp Med. 1997; 186(2):199-207. PMC: 2198980. DOI: 10.1084/jem.186.2.199. View

18.

Mueller-Ortiz S, Hollmann T, Haviland D, Wetsel R . Ablation of the complement C3a anaphylatoxin receptor causes enhanced killing of Pseudomonas aeruginosa in a mouse model of pneumonia. Am J Physiol Lung Cell Mol Physiol. 2006; 291(2):L157-65. DOI: 10.1152/ajplung.00358.2005. View

19.

Li K, Anderson K, Peng Q, Noble A, Lu B, Kelly A . Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood. 2008; 112(13):5084-94. DOI: 10.1182/blood-2008-05-156646. View

20.

Schultz M, Knapp S, Florquin S, Pater J, Takeda K, Akira S . Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa. Infect Immun. 2003; 71(4):1630-4. PMC: 152024. DOI: 10.1128/IAI.71.4.1630-1634.2003. View